CHAO DAVID M — SEC Form 4 filings
SEC reporting owner CIK 1861871. 7 Form 4 filings on record with FilingPulse; latest filed 2025-03-19.
Transaction summary — filings shown
Covers all 7 filings on record, filed 2024-02-02 to 2025-03-19. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): none reported.
- Open-market sales (code S, non-derivative): 2 legs across 1 filing — 7,000 shares, $120,206 total (shares × price as filed).
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 10.
- Largest priced transaction: sale of 5,478 shares @ $17.08 ($93,576) in Centessa Pharmaceuticals plc, filed 2025-03-19.
By issuer — same filings
Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Issuer | Role (as filed) | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|---|
| Centessa Pharmaceuticals plc (CNTA) | Chief Administrative Officer | 7 | — | 2 legs · 7,000 sh · $120,206 | 10 |
Form 4 filings — CHAO DAVID M
| Filed | Form | Issuer | Reported transactions | Source |
|---|---|---|---|---|
| 2025-03-19 | 4 | Centessa Pharmaceuticals plc (CNTA) | Option exercise (M): 3,500 @ $3.85 · Sale (S): 5,478 @ $17.08 · Sale (S): 1,522 @ $17.50 · Option exercise (M): 3,500 (derivative) @ $0 | EDGAR |
| 2025-02-04 | 4 | Centessa Pharmaceuticals plc (CNTA) | Tax withholding (F): 13,324 @ $16.92 | EDGAR |
| 2024-12-31 | 4 | Centessa Pharmaceuticals plc (CNTA) | Tax withholding (F): 10,385 @ $16.35 | EDGAR |
| 2024-10-02 | 4 | Centessa Pharmaceuticals plc (CNTA) | Tax withholding (F): 10,385 @ $15.79 | EDGAR |
| 2024-07-02 | 4 | Centessa Pharmaceuticals plc (CNTA) | Tax withholding (F): 10,385 @ $9.03 | EDGAR |
| 2024-04-02 | 4 | Centessa Pharmaceuticals plc (CNTA) | Tax withholding (F): 10,385 @ $11.30 | EDGAR |
| 2024-02-02 | 4 | Centessa Pharmaceuticals plc (CNTA) | Grant/award (A): 37,500 @ $0 · Tax withholding (F): 9,503 @ $8.19 · Grant/award (A): 150,000 (derivative) @ $0 | EDGAR |
FilingPulse's Form 4 archive currently extends back to 2024-01-11 and is expanding backward through EDGAR history — earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.
Need this as JSON?
GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1861871 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. API docs →